**Core Concept**
In chronic alcoholism, the primary metabolic pathway for ethanol is catalyzed by alcohol dehydrogenase (ADH), which converts ethanol to acetaldehyde. This reaction requires **NAD+** as a coenzyme. The rate-limiting step in this pathway is the availability of NAD+, as its depletion due to sustained alcohol metabolism can impair overall alcohol clearance.

**Why the Correct Answer is Right**
Alcohol dehydrogenase (ADH) catalyzes the oxidation of ethanol to acetaldehyde, a reaction that **requires NAD+** as a cofactor. During this process, NAD+ is reduced to NADH. In chronic alcoholism, continuous ethanol metabolism leads to **depletion of NAD+**, making it the **rate-limiting factor** in the pathway. While NADP and NADPH are involved in other metabolic pathways (like fatty acid synthesis), they are not directly involved in ethanol metabolism. FADH is involved in the electron transport chain and not in ADH activity.

**Why Each Wrong Option is Incorrect**
Option A: NADP is not a cofactor in ethanol metabolism; it plays a role in anabolic pathways, not in alcohol oxidation.
Option C: NADPH is involved in reductive biosynthesis and antioxidant defense, not in ethanol metabolism.
Option D: FADH is a reduced form of flavin adenine dinucleotide, involved in the Krebs cycle and electron transport, not in ADH activity.

**Clinical Pearl / High-Yield Fact**
In chronic alcoholism, **NAD+ depletion** impairs the body’s ability to metabolize ethanol efficiently, leading to accumulation of acetaldehyde and contributing to conditions like Wernicke-Korsakoff syndrome due to impaired pyridine nucleotide metabolism.

✓ Correct Answer: B. NAD+